Chinese e-commerce giant Alibaba is to move its online pharmaceutical operations to Alibaba Health Information Technology (AHIT), a Hong Kong-listed subsidiary, increasing its stake from 38% to 55%. Shares in AHIT soared 85% to HK$12.6 after the announcement.